Overview
Transient neonatal endocrine disorders encompass a range of conditions characterized by temporary hormonal imbalances affecting neonatal growth, metabolism, and development. Early recognition and intervention are crucial to mitigate morbidity and mortality 1.Diagnosis
Clinical Presentation: Symptoms may include hypoglycemia, jaundice, feeding difficulties, and growth retardation 1.
Recommended Tests: Blood glucose levels, thyroid function tests (TFTs), cortisol levels, and electrolyte panels 1.
Grading: Severity often correlates with clinical symptoms and laboratory abnormalities, requiring individualized assessment 1.Management
First-Line Treatments:
- Hypoglycemia: Immediate glucose infusion (initiate with 2-4 mg/kg/min IV dextrose solution) 1.
- Thyroid Dysfunction: Thyroxine supplementation if hypothyroidism is confirmed 1.
Adjunctive Treatments:
- Metabolic Support: Address electrolyte imbalances and provide nutritional support tailored to the specific disorder 1.
- Monitoring: Frequent clinical and laboratory monitoring to adjust treatments as needed 1.Special Populations
Pediatric Considerations: Neonatal endocrine disorders require careful monitoring and individualized management plans due to rapid developmental changes 1.Key Recommendations
Early recognition and prompt stabilization of neonatal endocrine emergencies are critical to improve outcomes (Evidence: Strong 1).
Initiate glucose therapy for neonatal hypoglycemia with IV dextrose as needed to maintain blood glucose levels above 70 mg/dL (Evidence: Moderate 1).
Confirm thyroid dysfunction with TFTs before initiating thyroxine supplementation in neonates with suspected hypothyroidism (Evidence: Moderate 1).References
1 Kim GK, Siller AF, Craven M, Bansal N. Neonatal Endocrine Emergencies. Advances in pediatrics 2025. link